作者
Wui-Jin Koh,Nadeem R. Abu‐Rustum,Sarah M. Bean,Kristin Bradley,Susana M. Campos,Kathleen R. Cho,Hye Sook Chon,Christina Chu,Rachel Clark,David E. Cohn,Marta A. Crispens,Shari Damast,Oliver Dorigo,Patricia J. Eifel,Christine M. Fisher,Peter J. Frederick,David K. Gaffney,Ernest Han,Warner K. Huh,John R. Lurain,Andrea Mariani,David G. Mutch,Christa Nagel,Larissa Nekhlyudov,Amanda N. Fader,Steven W. Remmenga,R. Kevin Reynolds,Todd D. Tillmanns,Stefanie Ueda,Emily Wyse,Catheryn M. Yashar,Nicole R. McMillian,Jillian L. Scavone
摘要
Cervical cancer is a malignant epithelial tumor that forms in the uterine cervix. Most cases of cervical cancer are preventable through human papilloma virus (HPV) vaccination, routine screening, and treatment of precancerous lesions. However, due to inadequate screening protocols in many regions of the world, cervical cancer remains the fourth-most common cancer in women globally. The complete NCCN Guidelines for Cervical Cancer provide recommendations for the diagnosis, evaluation, and treatment of cervical cancer. This manuscript discusses guiding principles for the workup, staging, and treatment of early stage and locally advanced cervical cancer, as well as evidence for these recommendations. For recommendations regarding treatment of recurrent or metastatic disease, please see the full guidelines on NCCN.org.